Delivery Order SPE2DB24D3014-SPE2DB25FKSPB

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,149.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for Sandostatin LAR Depot 10 mg kits, a specialty medication. The award has an ultimate completion date of January 22, 2025 and a firm fixed price pricing type. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,406.89 firm fixed-price delivery order is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication. The contract has an ultimate completion date of November 22, 2024 and was awarded on November 21, 2024. It is not designated as a set-aside contract. This award is likely...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,914.52 firm fixed-price delivery order is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication. The award is a task order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Sandostatin LAR Depot 30 mg kits. The award, valued at $12,669.03, is a Firm Fixed Price delivery order contract with an ultimate completion date of August 7, 2024. The contract does not have a set-aside designation. As a prime contractor, AmerisourceBergen will be responsible for supplying this critical pharmaceutical product...
This federal contract award is for a Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Sandostatin LAR Depot 30 mg kits. The award, with a ceiling value of $21,118.00, is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a potential value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,496.96 firm fixed-price contract is for the delivery of Sandostatin LAR Depot 30 mg Kits, a specialty medication. The contract has an ultimate completion date of April 2, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,648.30 firm fixed price contract is for the delivery of Sandostatin LAR Depot 20 mg kits, a pharmaceutical product used to treat certain medical conditions. The award is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $31,716.72 firm-fixed-price contract is for the supply of Sandostatin LAR Depot 20 mg kits, a specialty medication. The award has an ultimate completion date of December 21, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,609.10 firm fixed-price delivery order is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $51,582.00 firm fixed-price delivery order is for the supply of Sandostatin LAR Depot 30 mg kits. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as the primary vehicle for...
  • SPE2DB24D3014
    Indefinite Delivery Contract
  • SPE2DB24D3014-SPE2DB25FKSPB
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,168.76 firm fixed-price delivery order is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication. The contract has an ultimate completion date of January 30, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation was used for this specific award.

Generated 5/4/25, 12:42 AM